Literature DB >> 19252221

Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice.

Harmen Wiersma1, Alberto Gatti, Niels Nijstad, Folkert Kuipers, Uwe J F Tietge.   

Abstract

High density lipoprotein cholesterol is thought to represent a preferred source of sterols secreted into bile following hepatic uptake by scavenger receptor class B type I (SR-BI). The present study aimed to determine the metabolic effects of an endothelial lipase (EL)-mediated stimulation of HDL cholesterol uptake on liver lipid metabolism and biliary cholesterol secretion in wild-type, SR-BI knockout, and SR-BI overexpressing mice. In each model, injection of an EL expressing adenovirus decreased plasma HDL cholesterol (P < 0.001) whereas hepatic cholesterol content increased (P < 0.05), translating into decreased expression of sterol-regulatory element binding protein 2 (SREBP2) and its target genes HMG-CoA reductase and LDL receptor (each P < 0.01). Biliary cholesterol secretion was dependent on hepatic SR-BI expression, being decreased in SR-BI knockouts (P < 0.001) and increased following hepatic SR-BI overexpression (P < 0.001). However, in each model, biliary secretion of cholesterol, bile acids, and phospholipids as well as fecal bile acid and neutral sterol content, remained unchanged in response to EL overexpression. Importantly, hepatic ABCG5/G8 expression did not correlate with biliary cholesterol secretion rates under these conditions. These results demonstrate that an acute decrease of plasma HDL cholesterol levels by overexpressing EL increases hepatic cholesterol content but leaves biliary sterol secretion unaltered. Instead, biliary cholesterol secretion rates are related to the hepatic expression level of SR-BI. These data stress the importance of SR-BI for biliary cholesterol secretion and might have relevance for concepts of reverse cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252221      PMCID: PMC2724056          DOI: 10.1194/jlr.M800434-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  47 in total

Review 1.  Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

2.  A novel endothelial-derived lipase that modulates HDL metabolism.

Authors:  M Jaye; K J Lynch; J Krawiec; D Marchadier; C Maugeais; K Doan; V South; D Amin; M Perrone; D J Rader
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

3.  Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase.

Authors:  Weijun Jin; Gwo-Shing Sun; Dawn Marchadier; Edelyn Octtaviani; Jane M Glick; Daniel J Rader
Journal:  Circ Res       Date:  2003-02-27       Impact factor: 17.367

4.  Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism.

Authors:  Ke Ma; Mehmet Cilingiroglu; James D Otvos; Christie M Ballantyne; Ali J Marian; Lawrence Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

5.  Dose-dependent acceleration of high-density lipoprotein catabolism by endothelial lipase.

Authors:  Cyrille Maugeais; Uwe J F Tietge; Uli C Broedl; Dawn Marchadier; William Cain; Mary G McCoy; Sissel Lund-Katz; Jane M Glick; Daniel J Rader
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

6.  Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis.

Authors:  Laurent O Martinez; Sébastien Jacquet; Jean-Pierre Esteve; Corinne Rolland; Elena Cabezón; Eric Champagne; Thierry Pineau; Valérie Georgeaud; John E Walker; François Tercé; Xavier Collet; Bertrand Perret; Ronald Barbaras
Journal:  Nature       Date:  2003-01-02       Impact factor: 49.962

Review 7.  Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis.

Authors:  Bernardo L Trigatti; Monty Krieger; Attilio Rigotti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-08-14       Impact factor: 8.311

8.  Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo.

Authors:  Weijun Jin; John S Millar; Uli Broedl; Jane M Glick; Daniel J Rader
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

9.  Effects of nonlipolytic ligand function of endothelial lipase on high density lipoprotein metabolism in vivo.

Authors:  Uli C Broedl; Cyrille Maugeais; Dawn Marchadier; Jane M Glick; Daniel J Rader
Journal:  J Biol Chem       Date:  2003-08-08       Impact factor: 5.157

10.  Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice.

Authors:  Astrid Kosters; Raoul J J M Frijters; Frank G Schaap; Edwin Vink; Torsten Plösch; Roelof Ottenhoff; Milan Jirsa; Iris M De Cuyper; Folkert Kuipers; Albert K Groen
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

View more
  25 in total

1.  Cooperation between hepatic cholesteryl ester hydrolase and scavenger receptor BI for hydrolysis of HDL-CE.

Authors:  Quan Yuan; Jinghua Bie; Jing Wang; Siddhartha S Ghosh; Shobha Ghosh
Journal:  J Lipid Res       Date:  2013-08-29       Impact factor: 5.922

2.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

Authors:  Andrew A Francis; Grant N Pierce
Journal:  Exp Clin Cardiol       Date:  2011

Review 3.  Update on HDL receptors and cellular cholesterol transport.

Authors:  Ginny Kellner-Weibel; Margarita de la Llera-Moya
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

4.  ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma.

Authors:  Wijtske Annema; Arne Dikkers; Jan Freark de Boer; Thomas Gautier; Patrick C N Rensen; Daniel J Rader; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2012-03-01       Impact factor: 5.922

Review 5.  High-density lipoprotein heterogeneity and function in reverse cholesterol transport.

Authors:  George H Rothblat; Michael C Phillips
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

6.  Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver.

Authors:  Makoto Kurano; Masumi Hara; Koichi Tsuneyama; Koji Okamoto; Naoyuki Iso-O; Teruhiko Matsushima; Kazuhiko Koike; Kazuhisa Tsukamoto
Journal:  J Lipid Res       Date:  2012-08-13       Impact factor: 5.922

7.  The ABCG5 ABCG8 sterol transporter opposes the development of fatty liver disease and loss of glycemic control independently of phytosterol accumulation.

Authors:  Kai Su; Nadezhda S Sabeva; Jingjing Liu; Yuhuan Wang; Saloni Bhatnagar; Deneys R van der Westhuyzen; Gregory A Graf
Journal:  J Biol Chem       Date:  2012-06-19       Impact factor: 5.157

8.  Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics.

Authors:  Daniel B Larach; Marina Cuchel; Daniel J Rader
Journal:  Clin Lipidol       Date:  2013-12

9.  PK/PD Disconnect Observed with a Reversible Endothelial Lipase Inhibitor.

Authors:  Jon J Hangeland; Lynn M Abell; Leonard P Adam; Ji Jiang; Todd J Friends; Lauren E Haque; James Neels; Joelle M Onorato; Alice Ye A Chen; David S Taylor; Xiaohong Yin; Thomas W Harrity; Michael D Basso; Richard Yang; Paul G Sleph; David A Gordon; Christine S Huang; Ruth R Wexler; Heather J Finlay; R Michael Lawrence
Journal:  ACS Med Chem Lett       Date:  2018-06-15       Impact factor: 4.345

10.  GRP78 rescues the ABCG5 ABCG8 sterol transporter in db/db mice.

Authors:  Yuhuan Wang; Kai Su; Nadezhda S Sabeva; Ailing Ji; Deneys R van der Westhuyzen; Fabienne Foufelle; Xia Gao; Gregory A Graf
Journal:  Metabolism       Date:  2015-08-15       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.